Tipificación de virus del papiloma humano mediante secuencia directa en mujeres con citología normal

Parkin DM, Bray F, Ferlay J, Pisani P Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94(2):153-156. https://doi.org/10.1002/ijc.1440

Medina R. Atlas de mortalidad por cáncer en Colombia 1990. Bogotá: Instituto Nacional de Cancerología;1994.vol. 1,p.76-77.

Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189(1): 12-19. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F

De Villiers E. Taxonomic classification of Papillomaviruses. Papillomavirus Report 2001; 12(3):57-63.

Muñoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348(6):518-527. https://doi.org/10.1056/NEJMoa021641

Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87(11):796-802. https://doi.org/10.1093/jnci/87.11.796

Giroglou T, Sapp M, Lane C, Fligge C, Christensen ND, Streeck RE et al. Immunological analyses of human papillomavirus capsids. Vaccine 2001; 19(13-14):1783-1793. https://doi.org/10.1016/S0264-410X(00)00370-4

Vernon SD, Unger ER, Williams D. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol 2000;38(2):651-655. https://doi.org/10.1128/JCM.38.2.651-655.2000

Johnson T, Bryder K, Corbet S, Fomsgaard A. Routine genotyping of human papillomavirus samples in Denmark. APMIS 2003; 111 (3):398-404. https://doi.org/10.1034/j.1600-0463.2003.t01-1-1110204.x

GharizadehB, KalantariM, Garcia CA, Johansson B, Nyren P. Typing of human papillomavirus by pyrosequencing. Lab Inves12001;81(5):673-679. https://doi.org/10.1038/labinvest.3780276

Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287(16):2114-2119. https://doi.org/10.1001/jama.287.16.2114

Saiki RK, Scharf S, Faloona F, Mullís KB, Horn GT, Erlich HA et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230(4732):1350-1354. https://doi.org/10.1126/science.2999980

Roda-HusmanAM, Walboomers JM, Van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76(Pt 4):1057-1062. https://doi.org/10.1099/0022-1317-76-4-1057

Meissner JD. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J Gen Virol 1999;80 (Pt 7): 1725-1733. https://doi.org/10.1099/0022-1317-80-7-1725

Orita My Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5(4):874-879. https://doi.org/10.1016/0888-7543(89)90129-8

Terai M, Burk RD. Identification and characterization of 3 novel genital human papillomaviruses by overlapping polymerase chain reaction: candHPV89f candHPV90} andcandHPV91. J Infect Dis 2002;185(12):1794-1797. https://doi.org/10.1086/340824

Astori G, Arzese A, Pipan C, De Villiers EM, Botta GA. Characterization of a putative new HPV genomic sequence from a cervical lesion using L1 consensus primers and restriction fragment length polymorphism. Virus Res 1997;50(1):57-63. https://doi.org/10.1016/S0168-1702(97)00054-3

Cuzick J. Role of HPV testing in clinical practice. Virus Res 2002;89(2):263-269. https://doi.org/10.1016/S0168-1702(02)00194-6

Petry KU, Menton S, Menton M, Loenen-Frosch F, De Carvalho GH, Holz B et al. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br J Cancer 2003;88(10):1.570-1.577. https://doi.org/10.1038/sj.bjc.6600918

Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001;357 (9271): 1831-1836. https://doi.org/10.1016/S0140-6736(00)04956-4

Lazcano-Ponce E, Herrero R, Munoz N, Cruz A, Shah KV, Alonso P et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001;91(3):412-420. https://doi.org/10.1002/1097-0215(20010201)91:3<412::AID-IJC1071>3.0.CO;2-M

Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N et al. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000;87(2):221-227. https://doi.org/10.1002/1097-0215(20000715)87:2<221::AID-IJC11>3.0.CO;2-2

Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chong S et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 2000; 163(5):503-508.

Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92(6):464-474. https://doi.org/10.1093/jnci/92.6.464

Molano M, Posso H, Weiderpass E, Van den Brule AJ, Ronderos M, Franceschi S etal. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002; 87(3):324-333. https://doi.org/10.1038/sj.bjc.6600442

Peyton CL, Gravitt PE, Hunt WC, Hundley RS, Zhao M, Apple RJ et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001;183(11):1.554-1.564. https://doi.org/10.1086/320696